Stockreport

Neurocrine gets U.S. nod for Parkinson's therapy; COVID-19 delays launch [Reuters]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF Neurocrine gets U.S. nod for Parkinson's therapy; COVID-19 delays launch (Reuters) - Neurocrine Biosciences Inc said on Monday its add-on treatment for patients with Par [Read more]